
Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.

June 28, 2022
Founded in 1987 by Cyrus Mehta and Nitin Patel, research scientists at Harvard University and MIT respectively and...
Read article

April 12, 2022
Career Perspectives: Interview with Charles Warne, Associate Director of Biostatistics
In this edition of the Career Perspectives series, I interview Charles Warne, Associate Director of Biostatistics at...
Read article

March 8, 2022
How to conduct better time-to-event analysis with delayed treatment effects
The issue of delayed treatment effects in immuno-oncology was demonstrated during a FDA-Industry sponsored workshop...
Read article

August 18, 2021
What does reducing the risk of a faulty conclusion mean: Case study
During the design of a clinical trial, many biotechs want to substantially reduce the risk of a good new therapy being...
Read article

August 13, 2021
Finding the Optimal Trial Design Using Operations Research Methods
With the cloud computing power that we have today, we can run simulation of 1000s of designs with each design...
Read article

July 28, 2021
Lessons Learned from Leveraging Computing Power for Clinical Strategy
“We found an optimal design in hours that might have taken months to find using standard methods,” reflected Fabien...
Read article

July 22, 2021
The Risk of Under-exploring Trial Design Options: A New Case Study
Earlier this year, Cytel founder Cyrus Mehta observed that clinical trial design is often treated like an art rather...
Read article

July 14, 2021
Novel Uses of Scoring Functions in Clinical Trial Design Selection
For decades, statisticians have cultivated methods to optimize and de-risk clinical trials for strong regulatory...
Read article

July 12, 2021
Using Confidence Distributions to Manage Statistical Heterogeneity
Medical researchers and public health experts are becoming more reliant on meta-analyses to capture in summary form,...
Read article

July 7, 2021
Ensuring You Get Optimal Study Power for Your Investment
Suppose a statistician were to tell a clinical trial sponsor that it was possible to improve the power of the sponsor’s...
Read article

May 19, 2021
A Non-Technical Guide to Statistically-Informed Clinical Strategy
Clinical trial sponsors are more likely than ever to use the power of simulation and forecasting to evaluate the...
Read article

May 7, 2021
Never Miss the Optimal Study Design Options
When is a study design considered to be optimal? A good design performs well not only under the ideal target scenario...
Read article

April 28, 2021
Trial Selection: From Art to Science
Recently, Cytel co-founder Professor Cyrus Mehta noted that, “Clinical trial design selection is too much like an art,...
Read article

April 20, 2021
New Dimensions of Clinical Trial Optimization
For much of the past three decades, even as methodologies for clinical trial design have advanced and refined, the idea...
Read article

March 19, 2021
5 Steps to Regulatory Success with Wearables Designs
The use of wearable and digital technology requires considerations for both drugs and devices regulations, and...
Read article

March 18, 2021
Computing & Statistics: Are You Ready for the Industry Transformation?
Over the past ten years High-Performance Computing (HPC) has transformed medical research through advances in genomics,...
Read article

March 12, 2021
Wearables: Translating raw data to actionable information
With wearables likely to become a regular part of clinical trial design, statisticians could benefit by familiarizing...
Read article

February 26, 2021
Empowering Statisticians to Create Complex Bayesian Clinical Study Designs
In the world of clinical trials, the pace of innovation is accelerating, and approaches such as Bayesian methods are...
Read article

February 25, 2021
Use of Wearables in Confirmatory Clinical Trials
The convergence of several distinct trends has made wearables an increasingly attractive option for use in confirmatory...
Read article

February 11, 2021
The biostats and clinical overview of a growing clinical strategy
The past two years have witnessed a heightened interest in the use of wearables in clinical development. The unexpected...
Read article

January 26, 2021
Cytel Thought Leadership on Power of Bayesian Methods
Bayesian models offer a flexible way of incorporating historical controls in the analysis of trial data (whether single...
Read article

January 19, 2021
Cytel COVID Panel: Long-term Changes to Clinical Trials Due to the Pandemic
As we enter 2021 with new COVID-19 vaccines and greater optimism about the pipeline of drugs and devices positioned for...
Read article

January 13, 2021
How to Create a High-Quality Globally Distributed Biometrics Team?
Effective use of the right outsourcing solution can enable sponsors to respond to market needs and change course where...
Read article

December 22, 2020
Year-end Roundup: Cytel’s Contributions Towards Health & Education in 2020
At Cytel, we have been diligently working to become an organization deeply committed to uplifting and enriching...
Read article

December 17, 2020
2020 Recap by Yannis Jemiai, Chief Scientific Officer, Cytel
As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation...
Read article

December 15, 2020
Satisficing, Optimizing and Globally Optimizing Trial Designs
When designing clinical trials, biostatisticians and clinical development teams are often faced with a conundrum. Given...
Read article

December 10, 2020
Career Perspectives: Interview with Sachin Sobale
Sachin Sobale began his career with Cytel as a young statistician. He has been associated with the company for more...
Read article

December 9, 2020
7 Key Features of Strategic Clinical Trial Design
As a part of Cytel’s Advanced Design Framework, a new Framework for the statistical design of clinical trials, Cytel...
Read article

December 3, 2020
New Whitepaper: Reimagining Clinical-Trials
Increasing Clinical Development Productivity Using Statistics and Cloud-Computing The need for Re-imagining Clinical...
Read article

December 2, 2020
Program and Portfolio Optimization: A New Paradigm
Significant advances have been made to enhance the efficiency of clinical trial designs. However, the traditional...
Read article

November 18, 2020
We can design over 100,000 clinical trials in less than an hour
The current state of the clinical trials industry faces a challenge that was only hypothetical three or four years ago....
Read article

November 11, 2020
Interview with Yannis Jemiai: Advanced Design Framework
The widespread use of cloud-computing has altered the clinical trial design process. Whereas three or four years ago,...
Read article

November 4, 2020
Cytel Introduces Advanced Design Framework: Part 3 - Communication Techniques to Ensure Alignment on Data-Driven Clinical Trial Designs
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought leaders that draws on...
Read article

October 29, 2020
Advanced Design Framework: Part 2 - A Quantitative Evaluation Approach
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought leaders that draws on...
Read article

October 26, 2020
Need for Technology Solutions to Support Computationally
Pharmaceutical and biotech companies are under pressure to deliver more and deliver faster with fewer resources. The...
Read article

October 21, 2020
Advanced Design Framework: Part 1 - Exploration of Design Space
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought-leaders after a decade...
Read article

October 13, 2020
Introducing Observational Studies – Three Trends for Statisticians
The combination of greater access to electronic health records, bigger electronic claims datasets, and the need for...
Read article

October 5, 2020
The Meta-Analytic-Predictive Priors Generation and Comparisons
Staying abreast of the rapid pace of clinical development means adopting innovative or computationally intensive...
Read article

October 1, 2020
Improve Trial Design with Sequential Design and Sample Size
Methods involving Group Sequential Designs are one of the earliest deviations from a traditional two-arm clinical trial...
Read article

September 17, 2020
East Alloy: Accelerating the pace of innovation
Keeping up with the rapid pace of clinical development means that we need to adopt the innovative or computationally...
Read article

September 15, 2020
Accurately analyze small, skewed or sparse data with StatXact
In clinical trials with small or sparse data, statistical methods meant for large sample sizes may not be helpful to...
Read article

September 9, 2020
Importance of Designing Clinical Trials from a Program Perspective
Cytel’s co-founder, Nitin Patel, conducted a webinar on designing clinical trials from a program-level perspective. His...
Read article

September 1, 2020
FSP Navigator – Building the Team that Brings Success
In this blog, Cytel's SVP Corey Dunham’s talks about our Functional Services teams and the qualities we seek in new...
Read article

August 31, 2020
Adopt innovative and computationally intensive designs with East Alloy
Pantelis Vlachos, Principal, Strategic Consultant at Cytel, conducted a webinar to introduce the capabilities of East...
Read article

August 26, 2020
Career Perspectives: Interview with Yannis Jemiai, Chief Scientific Officer
As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation...
Read article

August 25, 2020
Nitin Patel on Designing Clinical Trials from a Program Perspective
It is important to take a strategic approach to clinical development in order to minimize the potential for Phase 3...
Read article

August 19, 2020
Webinar on Adaptive Designs for Dose Finding: Part 2
Bjoern Bornkamp, Statistical Methodologist at Novartis and Jose Pinheiro, Senior Director, Johnson & Johnson provided...
Read article

August 13, 2020
Webinar: Adaptive Designs for Dose Finding
Bjoern Bornkamp, Statistical Methodologist at Novartis and Jose Pinheiro, Senior Director, Johnson & Johnson provided...
Read article

August 12, 2020
Virtual Careers Open Day at Cytel
Cytel’s Biostatistics and Statistical Programming team provides integrated solutions, by blending the expertise of...
Read article

August 4, 2020
Estimands and their Implications on Clinical Studies
Last year, Paul Terrill, Associate Principal of Strategic Consulting at Cytel, presented an engaging webinar on the...
Read article

July 27, 2020
Introduction to Population Enrichment by Dr. Thomas Burnett
Cytel is conducting a webinar series on complex innovative trial designs. Dr. Thomas Burnett, Senior Research Associate...
Read article

July 22, 2020
Access Sustainable, Verified Innovation with East Alloy
Cytel brings to you a new blog series on technology and Bayesian decision-making by Pantelis Vlachos,...
Read article

July 13, 2020
Interview with Dr. Thomas Burnett on Adaptive Enrichment
Cytel is hosting a complimentary webinar series that introduces biostatisticians and other members of the development...
Read article

June 24, 2020
Webinar - Practical Model-based Approaches for Phase I Oncology Trials
Last week, Cytel conducted its third webinar in the new introductory webinar series on Complex Innovative Trial...
Read article

June 15, 2020
Significance of Bayesian Model-Based Approaches in Oncology Trials: An Interview with Dr. Satrajit Roychoudhury
Cytel conducted a webinar with Dr. Satrajit Roychoudhury, Senior Director, Statistical Research and Data Science...
Read article

June 10, 2020
Group Sequential Designs and Sample Size Re-estimation
Cytel is conducting a webinar series that introduces biostatisticians to some of the more commonly used complex...
Read article

June 1, 2020
Webinar Replay: Innovative Drug Development at a Glance
In a recent interview with Cytel, Zoran Antonijevic, longstanding chair and leader of the DIA Adaptive Design...
Read article

May 27, 2020
Group Sequential Designs and Sample Size Re-estimation
In this blog, we speak with Christopher Jennison, Professor of Statistics at the University of Bath, UK. Professor...
Read article

May 18, 2020
Interview with Zoran Antonijevic on Adaptive Design Methods
In this blog, we speak with Zoran Antonijevic, longstanding chair and leader of the DIA Adaptive Design Scientific...
Read article

April 27, 2020
Highlights from the 2020 Virtual CDISC EU Interchange - Part 2
In the first part of this two-parts blog, I speak about how the European CDISC Committee (E3C) together with CDISC...
Read article

April 24, 2020
Highlights from the 2020 Virtual CDISC EU Interchange by Angelo Tinazzi
In early March, when countries around the world started implementing lockdowns, the European CDISC Committee (E3C)...
Read article

March 5, 2020
Managing risk in clinical development: Is your data strategy fail-safe?
Generating high-quality clinical data is a vital but challenging task in modern drug development. Unfortunately, in the...
Read article

February 20, 2020
Unlock the power of your clinical data with these five top tips
It is widely acknowledged among drug developers that one of their most important assets is the data generated during...
Read article

November 5, 2019
Drug Development in Rare Diseases - Innovation in Statistical Thinking
Cytel is delighted to have Kannan Natarajan speaking at the “Complex Innovative Trial Design Symposium and East User...
Read article


January 10, 2019
Podcast: Overcoming Phase 1 Development Challenges
Nand Kishore Rawat is a Director and Head, Early Phase Biostatistics based in the King of Prussia, PA Cytel office. We...
Read article

December 5, 2018
Creating a Common Language: Forging Statistical and Clinical Collaborations
In this blog, Paul Terrill, Director of Strategic Consulting at Cytel outlines his blueprint for ensuring smooth...
Read article

November 12, 2018
Can Statisticians Contribute to Enhance the Position of Patients in Clinical Trials?
In this blog, we talk with Robert Greene, Founder and President of the HungerNDThirst Foundation, about his upcoming...
Read article


October 5, 2018
Interview with Stephen Senn: 70 Years and Still Here: The Randomized Clinical Trial and its Critics
We are delighted that Stephen Senn will be joining us at the EUGM on November 14th and 15th in Darmstadt, Germany. In...
Read article

September 20, 2018
Career Perspectives: Interview with Adam Hamm, Director of Biostatistics
At Cytel we believe that expert statistical input has the power to shape the future of clinical development: de-risking...
Read article

September 17, 2018
Novel immunotherapies lean on old methods
Immunotherapy has brought us many promises, most notably, of a future where humans are able to harness their body’s own...
Read article

September 10, 2018
Could data science be about to revolutionize the regulatory approval of new drugs?
The biopharmaceutical and healthcare industries now collect more data than ever before due to advances in the variety...
Read article

September 7, 2018
Opportunities of FDA’s Innovative Trial Design Pilot Meeting Program
On August 29th 2018, the FDA announced (1) that it would be establishing a Complex Innovative Trial Design (CID) Pilot...
Read article

August 31, 2018
Highlights from the JSM 2018 Conference
JSM 2018, ASA’s annual gathering of over 6500 attendees attracted statisticians and data scientists to the beautiful...
Read article

August 23, 2018
Career Perspectives: Interview with Meredith Alm, Manager, QA Compliance
Cytel has grown significantly over the last 30 years, with operations across North America, Europe, and India. All of...
Read article

July 24, 2018
Career Perspectives: Interview with Sam Hsiao, Associate Director, Strategic Consulting
At Cytel our strategic consulting team works on a wide range of projects including: Identifying the best clinical trial...
Read article

July 2, 2018
Highlights from the PSI 2018 Conference
A number of the Cytel team were in Amsterdam, 3rd- 6th June 2018 for the PSI Conference. This year’s conference was...
Read article

May 31, 2018
5 Reasons to Integrate MBMA Into Your Clinical Development Strategy
By Esha Senchaudhuri An important trend in clinical development involves integrating strategic pharmacometric analysis...
Read article

May 23, 2018
Addressing Critical Unmet Oncology Needs in the Era of Precision Medicine
Our Industry Voices series showcases our clients’ innovative work and breakthrough therapeutics in oncologic...
Read article

May 16, 2018
Rewriting the oncology textbook with cell-based immunotherapies
Our Industry Voices series showcases our clients’ innovative work and breakthrough therapeutics in oncologic...
Read article

May 9, 2018
Innovative Oncology Trial Designs in Practice
As we prepare to head to ASCO in under a month's time, we are pleased to share a new ebook that showcases some key...
Read article

April 18, 2018
Developing the Next Generation of Skills for Statistical Programmers
Our recent Clinical Biometrics Survey explored the views of respondents from across the statistical programming,...
Read article

March 16, 2018
Career Perspectives: Interview with Benjamin Esterni, Principal Biostatistician
At Cytel we believe that expert statistical input has the power to shape the future of clinical development: de-risking...
Read article

February 15, 2018
A Gatekeeping Procedure to Test a Group Sequential Design
A recent publication in Biometrics ‘A Gatekeeping Procedure to Test a Primary and a Secondary Endpoint in a Group...
Read article

February 13, 2018
Career Perspectives: Interview with Ursula Garczarek, Associate Director - Strategic Consulting
Our strategic consulting team work on projects such as: Identifying the best clinical trial design, implementing...
Read article

January 26, 2018
6 Innovative Trial Design Videos
The Cytel YouTube Channel hosts a wealth of video presentations from Cytel experts as well as external industry and...
Read article

November 9, 2017
The Cytel Story: In the Co-Founders' Own Words
In this blog we are excited to unveil a new project which we have been hard at work on over the last few months. 2017...
Read article

November 6, 2017
Asking the Right Questions of Your Data: Experiences in Model Informed Drug Development
At the Chief Medical Officer Summit earlier this year, Cytel's Director of Quantitative Pharmacology and...
Read article

September 29, 2017
Career Perspectives: Interview with Namrata Deshpande, Senior Team Lead
Namrata Deshpande, Senior Team Lead will be participating in a round table discussion at the Women in Statistics event...
Read article

September 20, 2017
Accurate Event Prediction in a Cardiovascular Outcomes Research Trial
In this blog we share a case study of work our strategic consulting team conducted supporting accurate event prediction...
Read article

September 18, 2017
How to handle conservativeness of Exact p-value?
By Ashwini Joshi For small sample data or rare events data, exact non-parametric tests perform better than asymptotic...
Read article

September 13, 2017
How can Novel Statistical Methods Tackle Antibiotic Resistance?
Antibiotic resistance is one of the greatest challenges facing human health today. We are excited to welcome Dr. Scott...
Read article

September 11, 2017
Design Concept for Basket Trials: Interview with Bob Beckman
At the East User Group meeting (EUGM) on 25th and 26th October, we will welcome a number of renowned industry speakers...
Read article

August 2, 2017
Case Study: Cross-study Efficiencies in Biometrics Outsourcing
As a biometrics -focused CRO, Cytel regularly works across a program of studies, providing data consistency, and...
Read article

July 26, 2017
Are Adaptive Designs the Answer to Oncology Development Success?
Sadly, clinical development of anti-cancer therapeutics faces particularly high rates of failure, even in the context...
Read article

July 19, 2017
Case Study: Seamless Independent Data Monitoring Committee Support
With adaptive and innovative trial designs on the rise, operational implementation of interim analyses, including...
Read article

July 13, 2017
Creating Data Visualizations with R and Shiny
By Tejasweeni Rajput It’s been known for centuries that a picture can tell a thousand words. In an era of new...
Read article

July 11, 2017
Collaboration Brings Success for the UK Adaptive Designs Working Group.
The Adaptive Designs and Multiple Testing Procedures Workshop (ADMTP), the first joint meeting of the Adaptive Designs...
Read article

July 6, 2017
When Biostatisticians Disagree About Ethics
By Esha Senchaudhuri The ethical benefits of adaptive clinical trials have been widely acclaimed: higher prospects for...
Read article

June 28, 2017
Under wraps: the importance of patient privacy
About the Author: Manjusha Gode has over 28 years' IT experience spanning delivery Management, quality management,...
Read article

June 12, 2017
Predictions of Pharmacodynamic Responses in Ulcerative Colitis Patient
The Population Approach Group in Europe (PAGE) represents a community with a shared interest in data analysis using the...
Read article
June 8, 2017
Measuring Intergroup Agreement and Disagreement
Cytel's Madhusmita Panda presented at this year’s PSI Conference in the Innovative Methodology session on the topic of...
Read article

May 30, 2017
Interview: How can a Bayesian framework support benefit risk assessment?
A recent paper The case for Bayesian methods in benefit-risk assessment: Overview and future directions (1) co-authored...
Read article

May 26, 2017
Cytel statistical programmer gains recognition at PharmaSUG 2017
PharmaSUG 2017 proved to be an inspirational and informative event. With over 200 paper presentations, posters, and...
Read article

May 22, 2017
Jim Bolognese named 2017 American Statistical Association Fellow
James (Jim) Bolognese, Senior Director, Strategic Consulting, Clinical Services at Cytel Inc. was named a 2017 fellow...
Read article

May 17, 2017
Case Study: From Trial Design to CDISC Submission
This new case study shares how Cytel supported a specialist biopharmaceutical company from Phase 2 trial design through...
Read article

April 28, 2017
Case Study: Redesigning a Pragmatic Trial in Oncology
In this blog we share a case study in which our statistical consulting team helped a client redesign an oncology...
Read article

April 25, 2017
Critical Operational Considerations for Interim Analyses
At a recent conference Adam Hamm, Director Biostatistics at Cytel, presented his thoughts on Best Practices and...
Read article

April 11, 2017
FDA 22 Case Studies and Mitigating Phase 3 Risks
In a January 2017 paper (1), the FDA reviewed 22 case studies where promising Phase 2 trials did not result in...
Read article

April 5, 2017
Better Management and Outputs in Statistical Programming
Statistical programmers at all levels can make a significant impact on streamlining delivery, improving efficiency, and...
Read article

March 29, 2017
New Publication: Design and Monitoring of Multi-Arm Multi-Stage Clinical Trials
With an increasing interest in platform designs and other innovative designs that involve multiple comparisons over...
Read article

March 24, 2017
Case Study: Improving Go/No-go Decision-Making with Custom Software
Robust go/no-go (GNG) decision-making is essential for effectively managing risk across a clinical portfolio. In early...
Read article

March 20, 2017
The Role of the Independent Randomization Center
In the randomized clinical trial (RCT), the process of deciding the randomization method and implementing is critically...
Read article

March 10, 2017
Flexible approaches to Biosimilars Development
At the recent Biosimilars Summit in Philadelphia, Cytel's Pantelis Vlachos presented on statistical challenges and...
Read article

March 2, 2017
Case Study: Bayesian Decision-Making in a Phase 3 Oncology Design
We continue our case study series with this example of a Phase 3 design that uses Bayesian decision making combined...
Read article

February 27, 2017
Estimands 101: Interview with Mouna Akacha
It’s been hard to miss the prevalence of estimand-related discussions in the last year. This is a topic which is very...
Read article

February 21, 2017
Syntax and Variables in R: A Primer
In a previous blog, we provided an overview of basic data structures in R. In this follow up piece, we will provide a...
Read article

February 15, 2017
Outsourcing success for emerging biopharma
Outsourcing solutions should never be a one size fits all process, and smaller and emerging biopharma companies may...
Read article

February 9, 2017
Inside an Oncology Statistician's Toolkit
In this blog, Adam Hamm, PhD, Director Biostatistics at Cytel shares some of the most important knowledge he uses in...
Read article

January 30, 2017
Accelerating development with combined SAD/MAD approach
Single ascending dose (SAD) and multiple ascending dose (MAD) studies are typically the first in human studies. They...
Read article

January 23, 2017
How to get the regulatory green light for your adaptive design?
As a group, Cytel had over 40 successful regulatory interactions last year, many of which supported approvals for...
Read article

January 19, 2017
Data Structures in R: A Primer
R is on the rise in biopharma, and as we have previously discussed on the blog, it is now time for SAS programmers to...
Read article

January 16, 2017
Adaptive Design Approaches from Cardiovascular Clinical Trialists Forum
The Global Cardiovascular Clinical Trialists Forum is a key event bringing together leading experts from across the...
Read article

January 5, 2017
SAS and NONMEM - a marriage made in heaven?
Nonlinear Mixed Effects Modeling (NONMEM) is a type of population pharmacokinetics/pharmacodynamics (popPK/PD) analysis...
Read article

December 15, 2016
Adaptive Design CONSORT Extension Project: The Inside Scoop
In April, we interviewed NIHR research fellow Munya Dimairo about the paper, ‘Adaptive designs undertaken in clinical...
Read article
December 2, 2016
Innovative Phase 3 Adaptive Enrichment Design in Oncology
At a recent Pfizer/ Cytel seminar on rare disease and oncology development, Cytel’s Lingyun Liu presented innovative...
Read article

November 18, 2016
Case Study: Dose-response modeling informs Phase 2 ulcerative colitis study design
Challenge Our client had the following key questions which they wanted our pharmacometrics group to address for an...
Read article
November 14, 2016
Infographic: 9 Do's and Don'ts to Ensure Independence of QC
In our last blog, we shared some of Angelo Tinazzi and Cedric Marchand's recommendations on how to ensure independence...
Read article

October 5, 2016
Challenges in Neuroscience Clinical Trials
While some progress has been made in terms of scientific development in Neuroscience and Neuropsychiatry indications,...
Read article

September 13, 2016
Case Study:Exposure Response Modeling in Hematology
Exposure-response data gained from clinical studies can provide a basis for model-based analysis and simulation,...
Read article
September 9, 2016
Case Study:Seamless Phase 2/3 Design in Rare Disease
Challenge: Our client, an emerging biotechnology company, was preparing for the next stage of development for their...
Read article

August 31, 2016
An Introduction to BLRM
Traditional rule-based approaches to dose escalation such as 3+3 are widely used in early clinical development. They...
Read article

August 26, 2016
Sample Size Re-Estimation in Bioequivalence Trials with Small Samples
At the recent JSM in Chicago, Cytel’s Sam Hsaio and Lingyun Liu alongside Genentech's Romeo Maciuca, presented a...
Read article

August 23, 2016
How does the T-Statistic stack up for finding MTD?
At the recent JSM meeting in Chicago, Cytel's Jim Bolognese presented the results of work he has conducted evaluating...
Read article

August 17, 2016
Adaptive Designs: In Conversation with the NEJM
Following the recent publication of their review article Adaptive Designs for Clinical Trials in the New England...
Read article

August 9, 2016
Operational and regulatory considerations in a promising zone trial
At the recent JSM Meeting, Cytel’s Yannis Jemiai presented the case study of the VALOR trial which used a promising...
Read article

July 18, 2016
Adaptive Design in the limelight with NEJM article
In order for adaptive designs to reach their potential, it’s critical that knowledge is effectively dissemirnated...
Read article

July 7, 2016
Wild Horses: How StatXact is helping conservation project in Mongolia
Why do we do what we do? At Cytel we have always been driven to deliver benefits in the service of human health, and...
Read article

June 21, 2016
Sharpening your Advanced SAS Skills: Interview with Sunil Gupta
Sunil is an Associate Director of Statistical Programming at Cytel and has over twenty-five years of experience in the...
Read article
June 14, 2016
Managing DMC analysis- an innovative programming solution
At Cytel, we are very often asked to get involved in DMCs ( Data Monitoring Committees) in a variety of capacities. Our...
Read article

June 7, 2016
How can the CMO/Biostatistician connection improve clinical development?
At the recent CMO Summit East James ( Jim) Bolognese, Cytel’s Senior Director of Strategic Consulting, and Lou...
Read article

May 31, 2016
EAST 6.4 Release: Interview with Yannis Jemiai
Last week, we were delighted to announce the release of East 6.4 bringing further cutting –edge approaches to the East...
Read article

May 19, 2016
Pattern Recognition and 'Big Data'
The explosion in healthcare information and “big data “has been one of the most written about topics in the last few...
Read article

May 17, 2016
Scrambled Data – A Population PK/PD Programming Solution
Cytel participated at PharmaSUG 2016 in Denver recently. A key event on the statistical programming global calendar,...
Read article

May 10, 2016
Subgroup Analyses in Early Phase Clinical Trials
We were fortunate to welcome Björn Bornkamp of Novartis to the EUGM 2016 presenting work he has developed jointly with...
Read article